biospecimen__admin__batch_number	425.45.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	A49EE0FE-A25A-4A6B-A695-DDA009EC9D5F
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-DD-AACZ-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-DD-AACZ-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-DD-AACZ-01A
biospecimen__bio__biospecimen_barcode_bottom	0174164276
biospecimen__bio__day_of_creation	08
biospecimen__bio__day_of_shipment	28
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	04
biospecimen__bio__month_of_shipment	05
biospecimen__bio__pathology_report_file_name	TCGA-DD-AACZ.8A8CB301-B3F2-469B-85D3-CAEA5A2F46ED.pdf
biospecimen__bio__plate_column	4
biospecimen__bio__plate_id	A41H
biospecimen__bio__plate_row	G
biospecimen__bio__quantity	3.20
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2014
biospecimen__bio__year_of_shipment	2014
biospecimen__shared__bcr_patient_barcode	TCGA-DD-AACZ
biospecimen__shared__patient_id	AACZ
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	15003256-FC7C-4662-9889-8F6777362338
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.8
clinical__chol_lihc_shared__albumin_result_specified_value	4.5
clinical__chol_lihc_shared__albumin_result_upper_limit	5.3
clinical__chol_lihc_shared__bilirubin_lower_limit	0.2
clinical__chol_lihc_shared__bilirubin_upper_limit	0.4
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.7
clinical__chol_lihc_shared__creatinine_upper_limit	1.5
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	0.6
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	8
clinical__chol_lihc_shared__fetoprotein_outcome_value	25
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	1.0
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	1.0
clinical__chol_lihc_shared__platelet_result_lower_limit	130
clinical__chol_lihc_shared__platelet_result_upper_limit	400
clinical__chol_lihc_shared__prothrombin_time_result_value	1.0
clinical__chol_lihc_shared__specimen_collection_method_name	Extended Lobectomy
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.2
clinical__chol_lihc_shared__vascular_tumor_cell_type	Macro
clinical__clin_shared__age_at_initial_pathologic_diagnosis	63
clinical__clin_shared__day_of_form_completion	29
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	1
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__month_of_form_completion	6
clinical__clin_shared__person_neoplasm_cancer_status	TUMOR FREE
clinical__clin_shared__platelet_result_count	412
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	NO
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__year_of_form_completion	2014
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2010
clinical__lihc_nte__new_tumor_event_ablation_embo_tx	Yes
clinical__lihc_nte__new_tumor_event_liver_transplant	No
clinical__nte__additional_pharmaceutical_therapy	NO
clinical__nte__additional_radiation_therapy	NO
clinical__nte__days_to_new_tumor_event_after_initial_treatment	88
clinical__nte__new_neoplasm_event_occurrence_anatomic_site	Liver
clinical__nte__new_neoplasm_event_type	Locoregional Recurrence
clinical__nte__new_tumor_event_additional_surgery_procedure	NO
clinical__nte__new_tumor_event_after_initial_treatment	YES
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G4
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T1
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	47ebb905-08f6-41c2-ae37-d296d499a2fc
gdc__aliquots__concentration	0.16
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-DD-AACZ-01A-11R-A41H-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	a90fc89c-0422-4f1d-b93f-d76ea4859f1e
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.82
gdc__analytes__analyte_id	d2637ced-73f5-4e21-bc7c-8e4f1d09c845
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	cce2bb32-84cb-4991-9628-1ea408a9b11a
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:30:09.587137-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	bac8cf91-e922-5754-9ee1-8c0ac6fe6c52
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	female
gdc__demographic__race	asian
gdc__demographic__year_of_birth	1947
gdc__demographic__year_of_death	2010
gdc__diagnoses__age_at_diagnosis	23230
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-23230.0
gdc__diagnoses__days_to_death	171.0
gdc__diagnoses__diagnosis_id	1994571a-62a6-5ef2-8e2e-5de2370ad01c
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage i
gdc__diagnoses__vital_status	dead
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	23.422368361785505
gdc__exposures__exposure_id	c959a902-5a30-5b6c-8a45-ed38c6688d1e
gdc__exposures__height	149.0
gdc__exposures__weight	52.0
gdc__file_id	cb351a12-c97b-4432-aca7-2cc9186b7fc1
gdc__file_name	bbb9946b-cdb3-4baf-b6d8-4de40280dfe9.mirbase21.mirnas.quantification.txt
gdc__file_size	50261
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	c7bbe69b084d339babbb97194a81ee31
gdc__portions__is_ffpe	false
gdc__portions__portion_id	d16a7e9d-a61a-402e-9862-558c7655ac9a
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	1147
gdc__samples__initial_weight	60.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	8A8CB301-B3F2-469B-85D3-CAEA5A2F46ED
gdc__samples__sample_id	b67f0f40-26ed-4fa0-b9b4-94686c48c593
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	0.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	0.0
gdc__slides__percent_tumor_cells	100.0
gdc__slides__percent_tumor_nuclei	90.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	5dbbc6c3-abfb-48bf-8908-005e65ac0231
gdc__submitter_id	mirna_swap_dr11_81_MirnaExpression65963689-af36-4807-9709-e85654c4747c_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	DD
gdc__tissue_source_site__name	Mayo Clinic - Rochester
gdc__tissue_source_site__tissue_source_site_id	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8
gdc__treatments__treatment_id	e8650e5b-f1bf-5bb0-80d6-c1550c3453f4
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:08:12.995+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/47ebb905-08f6-41c2-ae37-d296d499a2fc-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/47ebb905-08f6-41c2-ae37-d296d499a2fc-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129632
manually_curated__local_md5	8be0be818f75ab8ef3513fc1e109f4a2
manually_curated__opengdc_download_date	2018-10-16T17:12:25.000519+02:00
manually_curated__opengdc_file_md5	91340061de6fe71a9a81f3f48c8f2396
manually_curated__opengdc_file_size	50260
manually_curated__opengdc_id	47ebb905-08f6-41c2-ae37-d296d499a2fc-meq
manually_curated__origin_file_size	129632
manually_curated__origin_last_modified_date	Tue Oct 16 18:02:00 CEST 2018
manually_curated__origin_md5	8be0be818f75ab8ef3513fc1e109f4a2
manually_curated__tissue_status	tumoral
